ClinicalTrials.gg
RecruitingNCT06320496Updated May 8, 2026

Evaluation of the Effect of a Physical Activity Recovery Stay

An observational study in Children With Cerebral Palsy and Children With Cancer, sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est. Recruiting at 1 site in France. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est · Observational

How we know

From the registry’s dates

  • Started Mar 2022; still recruiting 4 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
8 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Cerebral Palsy with a site in France — 29 open to participants now, 30 under way, none of them phase 3. Cerebral Palsy · France.

Planned enrollment
20th of 32
50 · median 58
Started
2022
with 6 others
Observational
32 of 91
9 open now
Primary completion
2026-09
later than 5 of 29 live
Registered
66th of 91
by date
Lead sponsor
4 of 91
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Among the 91 studies in Cerebral Palsy with a site in France, this one is the 20th largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2022, is one of 32 observational ones, reaches primary completion later than 5 of the 29 other live ones, and was the 66th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

29 of the 91 studies in Cerebral Palsy with a site in France are open now. Recruiting first, the newest first:

24 more — sign in →

All 29 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 8 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Cerebral Palsy with a site in France, or all of them as a file.
02

Study summary

A WHO study in 2020 revealed that 81% of adolescents (aged 11-17) do not respect the recommendation of one hour of moderate physical activity per day. In the context of disability, many factors impose limits on physical activity. While the pathology itself induces limitations and restrictions (prolonged sitting time, assisted movement, etc.), organizational constraints also apply to both children and parents, who have to divide their time between work, school and therapeutic care, which is sometimes numerous and varied over the course of a single week. These limitations generate stress and fatigue, and prolonged sedentary periods lead children with chronic illnesses, rare diseases or disabilities into a process of physical deconditioning. The accumulation of sedentary time is detrimental to cardiovascular and metabolic health.

To combat this deconditioning, the 2008 National Physical Activity and Sport Plan (PNAPS) sets out the main guidelines for treatment and implementation. The plan explains that "for patients with chronic illnesses, rare diseases or disabilities, the aim is to encourage care and guidance towards Adapted Physical Activity (APA). The attending physician will be able to identify local therapeutic education programs, rehabilitation services and "sport-santé" offers, to improve access for these patients to supervised local programs". In addition, the plan suggests "developing APA programs in healthcare establishments to enable people with chronic illnesses, rare diseases or disabilities to access health education incorporating practical sessions".

In line with this plan, an exercise reconditioning program has been set up at our facility. This three-month stay includes children with a variety of pathologies, but with a common feature of physical deconditioning.

03

Conditions studied

  • Children With Cerebral Palsy
  • Children With Cancer

Browse trials for

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The children taking part in the return-to-physical-activity program are referred to the Flavigny-sur-Moselle CMPRE for medical consultation due to a state of deconditioning to physical exertion concomitant with a pathological situation. The pathology most frequently encountered during this stay is cerebral palsy. However, the Flavigny CMPRE is accredited in a number of fields (orthopedics, burns, neurology, oncology), and the pathologies of the children referred to this stay are representative of these. These include children with scoliosis, obesity, Guillain-Barré syndrome, cystic fibrosis, Charcot's disease and cancer.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with a pathology (chronic disease, rare disease or disability) in a state of deconditioning to exercise
  • Taken in charge at the CMPRE for a stay to resume physical activity

Exclusion criteria

Exclusion Criteria:

  • Age under 8 and over 18
  • Patients undergoing rehabilitation during the stay
  • Patients with a significant change in their therapeutic management during the stay
  • Significant cognitive impairment preventing comprehension of instructions
  • Significant club or leisure sports activity (3x/week)
  • Electric wheelchair
  • Non-compliance with stay (5 ½ days missed out of total stay)
  • Participation in another study during the return-to-physical-activity stay
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Deconditioning to physical exertion

    The children taking part in the return-to-physical-activity program are referred to the Flavigny-sur-Moselle CMPRE for medical consultation due to a state of deconditioning to physical exertion concomitant with a pathological situation. The pathology most frequently encountered during this stay is cerebral palsy. However, the Flavigny CMPRE is accredited in a number of fields (orthopedics, burns, neurology, oncology), and the pathologies of the children referred to this stay are representative of these. These include children with scoliosis, obesity, Guillain-Barré syndrome, cystic fibrosis, Charcot's disease and cancer.

06

What researchers measure

Primary outcomes

  1. Diagnoform test score

    To evaluate the effect of the return to physical activity stay prescribed by the doctors at the Flavigny CMPRE on the physical condition of the children taking part in the stay Score between 0 and 20 for each part of the test, with 20 being the best score (and therefore the best physical condition).

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

Secondary outcomes

  1. KidScreen52 quality-of-life scale score.

    Quality of life scale : a T-score value is calculated. Scores range from 10 to 50, where 10 represents the lowest possible value and thus a very low health-related quality of life and 50 the maximum value, i.e. a very high health-related quality of life.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  2. Impedance measurement

    Recording weight on a balance : Ideally, the patient should have lost weight by the end of the reconditioning stay.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  3. Exercise test on ergometer

    Three-minute warm-up without resistance, then increase in difficulty every minute until you reach 80% of your theoretical maximum heart rate.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  4. Anamnesis

    description of the antecedents

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  5. 6-minute walk test

    Walk the maximum distance for 6 minutes

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  6. Energy expenditure index

    Functional walking index calculated during a regular, spontaneous 5-minute walk. This index is equal to the ratio of heart rate averaged over the 5th minute to walking speed.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  7. Gluteal bridge

    Physical exercise that helps to strengthen the gluteus muscles (located in the buttocks) and hamstrings. The longer you hold the position, the better is.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  8. Shirado test

    Assessment of abdominal endurance: keep your shoulders off the ground while lying on your back with your feet raised. The maximum duration of this test is three minutes. Low performance if time less than 60 seconds, maximum if time greater than 150 seconds.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  9. Sorensen test

    Assessment of trunk extensor endurance: hold the weight of your trunk in isometric position for as long as possible, with your arms crossed over your chest. The maximum duration of this test is 240 seconds. The longer the position is maintained, the better.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  10. Timed Up and Down Stairs (TUDS) test

    he participant stands 1 foot from the bottom of a 14-step flight of stairs. The participant is instructed to "Quickly, but safely go up the stairs, turn around on the top step (landing) and come all the way down until both feet land on the bottom step (landing." The participants are allowed to choose any method of traversing the stairs. The TUDS score was the time in seconds from the "go" cue until the second foot returned to the bottom landing. Shorter times indicated better functional ability.

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  11. Floor survey test

    Evaluation and exercise element designed to teach the subject to get up from the ground using the righting sequence

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  12. Mini Bestest : Each of the 14 tests is graded from 0 to 2. "0" represents the lowest functional level and "2" the highest functional level. Maximal score : 28.

    Clinical assessment of postural control

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  13. The Canadian Occupational Performance Measure

    Tool used in occupational therapy to identify people's occupational problems

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

  14. A motivational questionnaire

    A tool for assessing involvement and motivation levels : 7 questions score between 0 and 10. 0 = no motivation 10 = total motivation

    Time frame: Day of patient inclusion and 3 months after, day on which the study ends for the patient

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2022 (actual). Primary completion is estimated for Sep 2026, 54 months after the start.

Of 217 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 54 months is above that.

Counting every sponsor, half of 221 studies reached it within 21 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Mar 20, 2024
StartActual
Mar 22, 2022
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06320496
Lead sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Responsible party
Sponsor
First posted
Mar 20, 2024
Start date
Mar 22, 2022
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
May 8, 2026

Study contacts

Jonathan Pierret, PhD
Contact
jonathan.pierret@ugecam.assurance-maladie.fr
+33 3 82 52 6761

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion